Sangair AB
Developing revolutionary blood treatment technology to combat severe sepsis infections.
Overview
- 5–9
- Employees
- 1–49K SEK
- Revenue
- 2016
- Founded
Key Decision Makers
Susanne Olausson
Board member
Johan Sjöholm
Board Member, Founder
Henrik Rundgren
Board member
Martin Wiklund
Board member
+2 more contacts in Funnelfeedr
Description
Sangair AB is a Swedish biotechnology company focused on developing innovative solutions for critical medical conditions. Their core innovation is SangAsept, a unique process designed to treat blood extracorporeally, meaning outside the body. This technology immediately targets and reduces harmful b...
Tags
Keywords
Company Information
- Industry
- Tillverkning av medicinska och dentala instrument och tillbehör
- Legal Form
- Aktiebolag
- VAT Number
- SE559080331701
Decision Makers
6 contacts in FunnelfeedrSusanne Olausson
Board member
Johan Sjöholm
Board Member, Founder
Henrik Rundgren
Board member
Martin Wiklund
Board member
Niclas Jonasson
Chairman of the Board
Other Contacts
Sara Weman
Engineer
Similar Companies
20 similar companies in Funnelfeedr
Modus Therapeutics Holding AB
1–4 employeesSwedish biotech developing sevuparin for severe inflammatory conditions.
Modus Therapeutics AB
Swedish biotech developing sevuparin for severe inflammatory diseases.
Gradientech AB
20–49 employeesDeveloping ultra-rapid diagnostic systems for antibiotic susceptibility testing.
bioMérieux Sweden AB
20–49 employeesWorld leader developing in vitro diagnostics for health and safety.
Aptahem AB
1–4 employeesBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Browse More
Sangair AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo